Myriad Genetics: Q4 Earnings Insights

Myriad Genetics MYGN reported its Q4 earnings results on Tuesday, February 27, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Myriad Genetics beat estimated earnings by 300.0%, reporting an EPS of $0.04 versus an estimate of $0.01.

Revenue was up $18.80 million from the same period last year.

Last quarter the company beat on EPS by $0.05 which was followed by a 9.0% increase in the share price the next day.

Here's a look at Myriad Genetics's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.08	-0.08	-0.19	-0.16
EPS Actual	-0.03	-0.08	-0.21	-0.12
Revenue Estimate	179.25M	187.13M	171.55M	169.46M
Revenue Actual	191.90M	183.50M	181.20M	177.80M

To track all earnings releases for Myriad Genetics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar